Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Several European countries have either suspended inoculations with the AstraZeneca Covid vaccine as a precautionary measure or banned the use of a specific batch after after blood clots formed in some people who had received the jab.
Both the Anglo-Swedish drugmaker and Europe’s medicines regulator said the vaccine was safe as Denmark, Norway and Iceland announced on Thursday they were temporarily halting all AstraZeneca vaccinations to investigate the cases.
Italy’s national medicines authority, meanwhile, followed Austria, Estonia, Latvia, Luxembourg and Lithuania in banning inoculations with one particular batch of AstraZeneca vaccines, consisting of 1m doses, which was sent to 17 countries.
The European Medicines Agency said this week that 22 cases of blood clots had been reported as of 9 March among more than 3 million people vaccinated with the AstraZeneca shot in Europe. There was no evidence so far linking AstraZeneca to the two cases in Austria, it said on Wednesday.
Both the Anglo-Swedish drugmaker and Europe’s medicines regulator said the vaccine was safe as Denmark, Norway and Iceland announced on Thursday they were temporarily halting all AstraZeneca vaccinations to investigate the cases.
Italy’s national medicines authority, meanwhile, followed Austria, Estonia, Latvia, Luxembourg and Lithuania in banning inoculations with one particular batch of AstraZeneca vaccines, consisting of 1m doses, which was sent to 17 countries.
The European Medicines Agency said this week that 22 cases of blood clots had been reported as of 9 March among more than 3 million people vaccinated with the AstraZeneca shot in Europe. There was no evidence so far linking AstraZeneca to the two cases in Austria, it said on Wednesday.
Several EU countries suspend AstraZeneca vaccine to investigate blood clot cases
European Medicines Agency say ‘benefits outweigh its risks’ and vaccine can continue to be used
www.theguardian.com